ArticleJournal of oncology2022

Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker.

Yaqi Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.